app_localeMedicare honlap
Nyelvválasztás megjegyzése.
1 év
first-party
The NIFTY (Non-Invasive Foetal Trisomy Test) is a safe and easy foetal risk test provided by GenePlanet to detect chromosomal abnormalities.
During pregnancy, a cell-free fragment of foetal DNA is released into the mother’s blood. Just over 5 ml of maternal venous blood is sufficient for NIFTY to test for foetal cell-free DNA.
The risk of fetal chromosomal abnormalities is assessed using next-generation sequencing (NGS) technology and bioinformatics analysis.

The NIFTY test is recommended from the 10th week of pregnancy (but not limited to):
Information regarding the gender of the fetus is available after the 12th week of pregnancy. If you have requested a gender determination, the preliminary report will be automatically updated once the results are available; no further action or special notification is required.
The result takes 12 days from the time the sample arrives at the laboratory.
Informational content only The textual content published on this page is for general information purposes only and does not constitute medical advice, a diagnosis, or a treatment recommendation. Proper assessment, examination, and therapeutic decisions always require a personal medical consultation and, where appropriate, further specialist opinion. Medicare Egészségközpont Zrt. makes every reasonable effort to keep the content up to date; however, it accepts no liability for the completeness or accuracy of the information published or for consequences arising from decisions based on it.